Sucro Ltd. (SUGR.V)
10.35
+0.10
(+0.98%)
CAD |
TSXV |
Oct 15, 16:00
Sucro Total Liabilities (Quarterly) : 698.21M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 698.21M |
| March 31, 2026 | 719.55M |
| December 31, 2025 | 663.68M |
| September 30, 2025 | 683.01M |
| June 30, 2025 | 602.51M |
| March 31, 2025 | 666.81M |
| December 31, 2024 | 684.53M |
| September 30, 2024 | 579.88M |
| Date | Value |
|---|---|
| June 30, 2024 | 489.66M |
| March 31, 2024 | 491.29M |
| December 31, 2023 | 550.47M |
| September 30, 2023 | 520.11M |
| June 30, 2023 | 489.70M |
| March 31, 2023 | |
| December 31, 2022 | 377.43M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Rhelion Life Sciences Corp. | 3.824M |
| TelyRx Holdings, Inc. | 28.32M |
| George Weston Ltd. | 40.13B |
| Loblaw Cos. Ltd. | 30.58B |
| Empire Co. Ltd. | 11.78B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.018B |
| Shareholders Equity (Quarterly) | 320.13M |
| Debt to Equity Ratio | 1.678 |
| Current Ratio | 1.243 |
| Net Debt Paydown Yield | -1.01% |